Phase III Study on Efficacy and Safety of Triple Combination (Exenatide/Metformin/Biphasic Insulin Aspart) Therapy for Type 2 Diabetes Mellitus

Author(s):

Ke Su ◽

Chunmei Lv ◽

Zongwen Ji ◽

Yishu Wang ◽

Haifeng Wang ◽

...

Keyword(s):

Diabetes Mellitus ◽

Type 2 Diabetes ◽

Insulin Aspart ◽

Phase Iii ◽

Efficacy And Safety ◽

Triple Combination ◽

Biphasic Insulin ◽

Phase Iii Study

Efficacy and Safety of PDM011011 Capsules as Compared to Metformin in Subjects with Type-2 Diabetes Mellitus: An Open-Label, Randomized, Active-Controlled, Multicentric, Phase III Study

Journal of Diabetes Mellitus ◽

10.4236/jdm.2016.61005 ◽

2016 ◽

Vol 06 (01) ◽

pp. 38-48 ◽

Author(s):

Ashish C. Suthar ◽

Vikas G. Pai ◽

Yogesh Kadam ◽

Aniruddha Tongaonkar ◽

Shailaja Kale ◽

...

Keyword(s):

Diabetes Mellitus ◽

Type 2 Diabetes ◽

Phase Iii ◽

Efficacy And Safety ◽

Open Label ◽

Phase Iii Study

Efficacy and safety of three-times-daily versus twice-daily biphasic insulin aspart 30 in patients with type 2 diabetes mellitus inadequately controlled with basal insulin combined with oral antidiabetic drugs

Diabetes Research and Clinical Practice ◽

10.1016/j.diabres.2019.02.023 ◽

2019 ◽

Vol 150 ◽

pp. 158-166 ◽

Author(s):

Wenying Yang ◽

Canan Ersoy ◽

Guixia Wang ◽

Shandong Ye ◽

Jun Liu ◽

...

Keyword(s):

Diabetes Mellitus ◽

Type 2 Diabetes ◽

Insulin Aspart ◽

Efficacy And Safety ◽

Oral Antidiabetic Drugs ◽

Biphasic Insulin ◽

Oral Antidiabetic ◽

Addition of biphasic insulin aspart 30 to rosiglitazone in type 2 diabetes mellitus that is poorly controlled with glibenclamide monotherapy

10.1016/s0149-2918(03)90095-6 ◽

2003 ◽

Vol 25 (12) ◽

pp. 3109-3123 ◽

Cited By ~ 17

Author(s):

Itamar Raz ◽

Ulrik Mouritzen ◽

Julius Vaz ◽

Tommy Hershkovitz ◽

Julio Wainstein ◽

...

Keyword(s):

Diabetes Mellitus ◽

Type 2 Diabetes ◽

Insulin Aspart ◽

Biphasic Insulin Aspart ◽

Biphasic Insulin ◽

Dapagliflozin as Monotherapy in Drug-Naive Asian Patients With Type 2 Diabetes Mellitus: A Randomized, Blinded, Prospective Phase III Study

10.1016/j.clinthera.2013.11.002 ◽

2014 ◽

Vol 36 (1) ◽

pp. 84-100.e9 ◽

Cited By ~ 89

Author(s):

Linong Ji ◽

Jianhua Ma ◽

Hongmei Li ◽

Traci A. Mansfield ◽

Caroline L. T’joen ◽

...

Keyword(s):

Diabetes Mellitus ◽

Type 2 Diabetes ◽

Phase Iii ◽

Asian Patients ◽

Prospective Phase ◽

Phase Iii Study ◽

Drug Naïve

Addition of biphasic insulin aspart 30 to optimized metformin and pioglitazone treatment of type 2 diabetes mellitus: The ACTION Study (Achieving Control Through Insulin plus Oral ageNts)

Diabetes Obesity and Metabolism ◽

10.1111/j.1463-1326.2007.00796.x ◽

2009 ◽

Vol 11 (1) ◽

pp. 27-32 ◽

Cited By ~ 24

Author(s):

P. Raskin ◽

G. Matfin ◽

S. L. Schwartz ◽

L. Chaykin ◽

P.-L. Chu ◽

...

Keyword(s):

Diabetes Mellitus ◽

Type 2 Diabetes ◽

Insulin Aspart ◽

Biphasic Insulin Aspart ◽

Biphasic Insulin ◽

Biphasic Insulin Aspart 30 ◽

Oral Agents ◽

Pioglitazone Treatment

Biphasic Insulin Aspart in Type??2??Diabetes Mellitus

Clinical Drug Investigation ◽

10.2165/00044011-200727050-00002 ◽

2007 ◽

Vol 27 (5) ◽

pp. 299-324 ◽

Cited By ~ 9

Author(s):

S C L Gough ◽

J Tibaldi

Keyword(s):

Diabetes Mellitus ◽

Type 2 Diabetes ◽

Insulin Aspart ◽

Biphasic Insulin Aspart ◽

Biphasic Insulin

A comparison of biphasic insulin aspart (biasp30) with biphasic human insulin (bhi30) for type 2 diabetes mellitus in real clinical practice – A systematic review and meta-analysis

Value in Health ◽

10.1016/j.jval.2013.03.781 ◽

2013 ◽

Vol 16 (3) ◽

pp. A157

Author(s):

P Wojciechowski ◽

M Gaweska ◽

A Caban ◽

B Jurkiewicz ◽

R Plisko ◽

...

Keyword(s):

Diabetes Mellitus ◽

Systematic Review ◽

Type 2 Diabetes ◽

Clinical Practice ◽

Insulin Aspart ◽

Meta Analysis ◽

Biphasic Insulin ◽

Real Clinical Practice

Twice-daily biphasic insulin aspart 30 versus biphasic human insulin 30: A double-blind crossover study in adults with type 2 diabetes mellitus

10.1016/s0149-2918(02)85129-3 ◽

2002 ◽

Vol 24 (4) ◽

pp. 530-539 ◽

Cited By ~ 64

Author(s):

Paul T. McSorley ◽

Patrick M. Bell ◽

Lisbeth Vestergård Jacobsen ◽

Allan Kristensen ◽

Anders Lindholm

Keyword(s):

Diabetes Mellitus ◽

Type 2 Diabetes ◽

Insulin Aspart ◽

Double Blind ◽

Biphasic Insulin ◽

Biphasic Insulin Aspart 30 ◽

Blind Crossover Study ◽

Double Blind Crossover Study

A crossover study of the combination therapy of metformin and exenatide or biphasic insulin aspart 30 in overweight or obese patients newly diagnosed with type 2 diabetes mellitus

Experimental and Therapeutic Medicine ◽

10.3892/etm.2017.4863 ◽

2017 ◽

Vol 14 (4) ◽

pp. 3279-3287 ◽

Author(s):

Huibiao Quan ◽

Huachuan Zhang ◽

Weiping Wei ◽

Tuanyu Fang ◽

Daoxiong Chen ◽

...

Keyword(s):

Diabetes Mellitus ◽

Type 2 Diabetes ◽

Combination Therapy ◽

Insulin Aspart ◽

Obese Patients ◽

Newly Diagnosed ◽

Biphasic Insulin ◽

Risk for nocturnal hypoglycemia with biphasic insulin aspart 30 compared with biphasic human insulin 30 in adults with type 2 diabetes mellitus: A meta-analysis

10.1016/j.clinthera.2009.08.011 ◽

2009 ◽

Vol 31 (8) ◽

pp. 1641-1651 ◽

Cited By ~ 39

Author(s):

Jaime A. Davidson ◽

Andreas Liebl ◽

Jens S. Christiansen ◽

Greg Fulcher ◽

Robert J. Ligthelm ◽

...

Keyword(s):

Diabetes Mellitus ◽

Type 2 Diabetes ◽

Human Insulin ◽

Insulin Aspart ◽

Meta Analysis ◽

Nocturnal Hypoglycemia ◽

Biphasic Insulin ◽